Jean Regina (@JeanThomasR) header
Jean Regina (@JeanThomasR) profile picture

PGY-4 in Switzerland. Interested in internal medicine, ID, clinical reasoning and research on low value care.

Joined January 2013
Photo by Jean Regina (@JeanThomasR)
AHA meeting and lipids so far: -statins work, even in older adults - fancy new drugs targeting IL-6 and lp(a) don't
1
19
Jean Regina retweeted
Why am I not very excited about this? I saw how TAVI started as an alternative for a much superior procedure in inoperative patients, they I saw how the industry gradually increased the indications. This is a repeat DeJa vu! Do you want me to predict to you the next target?
PROGRESS presented at #TCT2026: Among patients with moderate aortic stenosis and at-risk features, a TAVR strategy was superior to clinical surveillance in reducing the 2-year incidence of death or HF events. The primary endpoint was largely driven by HF hospitalizations, in the context of an unavoidable open-label design. A highly selected population, enriched for risk factors. Medical therapy may also have been suboptimal relative to current standards or evolving evidence. Finally, does intervening earlier in the natural history of the disease mean starting the durability clock sooner than necessary? nejm.org/doi/full/10.1056/NE…
8
7
57
14,345
The 1st of 2 new articles in CID critical of clinical guideline process is out. See academic.oup.com/cid/article… It is long past time clinical guidelines incorporate the humility of uncertainty & stop creating standards of care absent of reproducible prospective studies. @ABsteward
12
43
4
118
20,642
For older adults w/ newly diagnosed afib during hospitalization the 1-yr stroke risk w/o anticoag was low: 0.7% for CHA2DS2VASc 1-4 & 1.8% for 5-8 Given consensus of ≥2%/year, anticoag may be less compelling in hospital-detected AF but should still be individualized by risk
1
4
1
7
3,827
"The other evening, I received two normally welcome email alerts. The first informed me that an invitation to peer review had been accepted; the second, that a peer review had just been completed. The problem? These two emails came seven minutes apart and concerned the same reviewer" sciencedirect.com/science/ar…
3
1
8
4,666
Happy new year! To bring in 2026, let's rewind Here are the 2025 evidence updates for hospital medicine Paired with EBM teachable moments
1
17
2
29
10,381
Rethinking the routine: Are repeat blood cultures necessary after completion of infective endocarditis treatment? ✅ Just Accepted 🔗 bit.ly/489rqwy
1
11
19
2,287
🫀Rethinking the routine: Are repeat blood cultures necessary after completion of infective endocarditis treatment? 💡 Key takeaway: Early routine cultures in asymptomatic patients rarely catch relapses—guidelines now favor symptom-driven follow-up. How does your team monitor post-IE patients? #IDXposts #IEWiki
3
15
45
4,811
Should you repeat blood cultures after treating infective endocarditis? European and American guidelines don’t agree — but the evidence suggests you probably shouldn’t in asymptomatic patients. Discover our brief report just published in CID! tinyurl.com/ya3neew8
59
#TWDFNR Non-contrast head CT 👤 before LP in low-risk adult and children with suspected 🧠 ABM should not be performed and is potentially harmful 🙅 bit.ly/42jfX7A @JHospMedicine @JeanThomasR #VisualAbstract by @SuchitaSata
1
9
17
4,100
🆕💥 @CMIJournal @ESCMID Impact of 2020 EUCAST criteria on meropenem prescription for the treatment of Pseudomonas aeruginosa infections: an observational study in a university hospital #IDTwitter #medtwitter #TwitteRx #MedEd clinicalmicrobiologyandinfec…